Related Experiment Video
Updated: Jun 29, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Serum adhesion molecule levels in acute coronary syndrome among Indonesian patients
1Department of Internal Medicine, Faculty of Medicine University of Indonesia-Dr. Cipto Mangunkusumo Hospital, Jalan Diponegoro no. 71, Jakarta. idrus@hotmail.com
Aim:
to observe whether the VCAM and ICAM level in ACS patients were higher than those in coronary heart disease (CHD) patients. In addition, we would like to observe the cut off point of VCAM and ICAM level in ACS patients.
Methods:
in observational study, as many as 146 subjects were analyzed, consisting of 84 ACS patients, and 62 coronary heart disease (CHD) patients. This study were conducted at Dr. Cipto Mangunkusumo General Hospital (RSUPN-CM), Persahabatan Hospital, MMC Hospital and Medistra Hospital, Jakarta. The study was carried out from May 2005 to May 2006.
Results:
the VCAM level was higher in the group of ACS patients (mean 981.06 ng/mL, SD 319.28, CI 95%: 911.77-1050.35) than in that in the group of CHD (mean 915.23 ng/mL, SD 283.05, CI 95%: 843.35-987.11), but the difference is not significant. At cut-off point of VCAM level >or= 920.8 ng/mL, the highest sensitivity (57.14%) and highest specificity (67.74%) were found with ROC of 0.58. The ICAM level was higher in the group of ACS patients (mean 268.08 ng/mL, SD 72.75, CI 95%: 252.29/283.87) than that in the group of CHD (mean 245.18 ng/mL, SD 87.37, CI 95%: 222.99-267.37), but the difference is not significant. At cut-off point of ICAM level 248.6 ng/mL, the highest sensitivity (54.76%) and highest specificity (66.13%) were found with ROC of 0.62.
Conclusion:
it could be concluded that VCAM and ICAM level in ACS were higher than in CHD, but the difference is not significant. The VCAM and ICAM level are not the best parameter to differentiate between acute (ACS) and stable (CHD) condition.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome V: Nursing Management